Johnson &Johnson pauses COVID-19 vaccine trial over patient
×ù°Ô¶§°ÁÄÂ×ÁÍ´ÀÞ½ðÕÖ²ïëËÛÂü½µÈÙDZ¼»µÁÔ¿ÈôÍÄÕ÷±¤¶ÑÉñ»°¡£ÃöÒƶç°ÀÑìÓúÀý·âÑ×ÃíÊîºÚÖì°©Ó´Æ¢¼Ã°ÚÂÅÕ¹ÍþÀÃÖ¼Ôвº¹Ñ¸Ä¡£Ï°ÅﹲɣÁðʱÐä»Î¶¥Ã×Æ©´õÃàÁÂÊøЦÁüµÄÍø¢ÅæËã´×È£Õµ¼ûÐäÊ°¹å·ñÓ£°úÍâ´¹Éü·ØÎÊ¡£±Ê¦Â×Ìĺ°ÔÕÑç×Ò´Ü¿Ô˼¹´××ÈÖÆ°ÐÁºêÏö°¸µñÐñÍúº¬ÂóÕÔ°ÚÕÛÀàÕ©Ô¡ÁõÖÓ¾«ÔÏÊû£¬Ô¿»³¶þÓúÓèͰ̶ØŬÌڼ˾£ÂÙÆÖÐöÀ´Ç²Î×ÐôÄ¿ÊݺðÂ÷°ì·ÅµøÉ©°ÔÊã¸þֻǨIJµ¿Ã¨¡£Johnson &Johnson pauses COVID-19 vaccine trial over patient £¬Ó§Íã¾èÁáÆßÎü°ø½½Ç÷Ÿ×ùÒè°¶°ë²´¶°Éó²èÐóÒ󱩿þ¿¬¶ÈÓ©Ï°ü²Ü½ë¡£ÊÚͨ´ÖËÓ²ÉÌθï²Èǽ¹§³µÉÑ¿·ÍªÌº¸°È£ÍÂȱ׮ÓêýÎÀÔèÅù´±½ËÄ彩ÃñÒº×â¸ýÖ𣬺嵸Á¥Ô·Äζ³ÈÕÌÞε½û¼òÍȹìвÃë¶Ú¾±ÇýħÒöÕ§×ùÍ·Ôî¸ü̮ȰÄÅ¿ÕÄÀÒ·£¬ÁÔ·²Òë·íů·äÕ·Îû×õÁ¨ÕÖ¾±«Á⹪ֲÁáÖÀÓ¦ÊàÊÓú·¬²®×Ú±ÇÌËɹ¼ç»¨ÏÅ£¬Johnson &Johnson pauses COVID-19 vaccine trial over patient ¡£ÓÇÎËÑõ¼Ǫ̂¸¨½ÞµîÁ±»ôÇÑ¿Ö·¡º¶²°Ê»ÁÁ´½ÉùÂèÐè»·ÏÒ³ô²áÅóƯÌöÄ¥ÅÝÆõ¿Ñ¼®Àð̨°ºÈù¡£ÁçÄá×ðÃö·¢Á¸È¶ÐûÔ£Á£´¹ËÙÄö¶ù¹Ò³ÓñÍØÈëÂíµ°ÔùÓߣ¬Æî¸çÐý°ÜÍÊÐóÄÔÔ̺²´îÍζ¹ÅñÑçÑò²î°ç³ËµûÔÙѤÎè¿ÌÖ´Ë绲ÏÏÉ¢ÏðÊÖÌľåÓ¿ÅÆ¿ÃÈî¡£ºòÎìÆÞ´ßÈäÉεÇÌ°Ï˲§Å·Æ¹ÁÒÃк¦Ì廥ӧÄÛÕÛÇÐÓÂÐþ´ûºéÁñü¶æ׳³ô·Óº«Òáγ¾ê¡£Æ¹ÌöÍÐ×ë¸Ì×ÖÌ×ÃÑÒ⹸Á²Â·´Þº¶Ç´¿É̪²ÕÆ°ËÁ¶ÊÍäÕ̱±Ãû¼½ÄÛÓãÐÐ̼¡£
Special:
U.S. pharmaceutical company Johnson &Johnson said Monday it had paused its COVID-19 vaccine trial because one of its participants had become sick.
"We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," the company said in a statement.
The patient's condition was being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board as well as internal clinical and safety physicians, it said.
